Nephrocare Health Services Ltd vs Tarsons Products Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Nephrocare Health Services Ltd is ₹ 615.95 as of 30 Oct 15:30 . The P/E Ratio of Nephrocare Health Services Ltd changed from 66 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Tarsons Products Ltd changed from 37.2 on March 2022 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Nephrocare Health Services Ltd changed from ₹ 5072 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Tarsons Products Ltd changed from ₹ 3746 crore on March 2022 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Nephrocare Health Services Ltd for the Jun '26 is ₹ 289.21 crore as compare to the Mar '26 revenue of ₹ 277.18 crore. This represent the growth of 4.34% The revenue of Tarsons Products Ltd for the Jun '26 is ₹ 116.22 crore as compare to the Mar '26 revenue of ₹ 127.76 crore. This represent the decline of -9.03% The ebitda of Nephrocare Health Services Ltd for the Jun '26 is ₹ 67.78 crore as compare to the Mar '26 ebitda of ₹ 62.24 crore. This represent the growth of 8.9% The ebitda of Tarsons Products Ltd for the Jun '26 is ₹ 31.96 crore as compare to the Mar '26 ebitda of ₹ 41.1 crore. This represent the decline of -22.24% The net profit of Nephrocare Health Services Ltd changed from ₹ 20.11 crore to ₹ 31.97 crore over 7 quarters. This represents a CAGR of 30.33% The net profit of Tarsons Products Ltd changed from ₹ 4.02 crore to ₹ -1.44 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Nephrocare Health Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Tarsons Products Ltd changed from 20.76 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About Nephrocare Health Services Ltd

Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009.
Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre. Company offer comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.
The Company began journey in 2010 with the launch of its first dialysis clinic in Hyderabad.
It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd.

About Tarsons Products Ltd

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983.
The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021. Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals.
The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare.
Tarsons currently operate through five manufacturing facilities located in West Bengal.

FAQs for the comparison of Nephrocare Health Services Ltd and Tarsons Products Ltd

Which company has a larger market capitalization, Nephrocare Health Services Ltd or Tarsons Products Ltd?

Market cap of Nephrocare Health Services Ltd is 6,193 Cr while Market cap of Tarsons Products Ltd is 1,552 Cr

What are the key factors driving the stock performance of Nephrocare Health Services Ltd and Tarsons Products Ltd?

The stock performance of Nephrocare Health Services Ltd and Tarsons Products Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nephrocare Health Services Ltd and Tarsons Products Ltd?

As of October 31, 2026, the Nephrocare Health Services Ltd stock price is INR ₹615.95. On the other hand, Tarsons Products Ltd stock price is INR ₹291.75.

How do dividend payouts of Nephrocare Health Services Ltd and Tarsons Products Ltd compare?

To compare the dividend payouts of Nephrocare Health Services Ltd and Tarsons Products Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.